U.S. Software Stock News

Boise Cascade (BCC) has just reported its Q1 2026 results against a backdrop where recent quarters showed Q4 2025 revenue of about US$1.5b and basic EPS of roughly US$0.24, alongside trailing 12 month revenue of about US$6.4b and basic EPS of US$3.54. Over the past six reported quarters, revenue has ranged from roughly US$1.5b to US$1.7b while quarterly EPS has moved between about US$0.24 and US$2.34. This sets up the latest update as a check in on how margins are holding up across the...

AvalonBay Communities, Inc. recently reported past first-quarter 2026 results showing higher revenue of US$770.28 million and net income of US$325.73 million, issued new EPS guidance for the second quarter and full year 2026, completed US$500 million in share repurchases across two authorizations, and filed a US$40 million ESOP-related common stock shelf registration. This combination of stronger earnings, fresh guidance, and active capital management highlights how AvalonBay is balancing...

BWX Technologies (BWXT) has just wrapped up Q1 2026 with investors looking closely at how the recent revenue and EPS trajectory sets the tone for the new year, particularly after trailing 12 month net income of US$328.9 million and basic EPS of US$3.59 against a current share price of US$206.15. Over the last six reported quarters, revenue has moved from US$671.9 million in Q3 2024 to US$885.8 million in Q4 2025, while quarterly basic EPS has ranged from US$0.76 to US$1.02, giving investors a...

If you are wondering whether Catalyst Pharmaceuticals' recent share price puts it at a bargain or a stretch, the following sections break that question down into clear valuation checks. The stock last closed at US$30.86, with returns of 4.8% over the past week, 25.0% over the past month, 33.3% year to date and 33.8% over the past year, which raises questions about how that performance lines up with underlying value. Recent headlines around Catalyst Pharmaceuticals have focused on its...

BioMarin Pharmaceutical (BMRN) opened 2026 with Q1 results that build on a run of quarterly revenue between US$745.1 million and US$874.6 million over 2025, while EPS has swung from a profit of US$1.25 in Q2 2025 to a loss of US$0.24 in Q4 2025 as one off items fed into the reported figures. Over the last six reported quarters, revenue has ranged from about US$745.1 million to US$874.6 million and trailing 12 month EPS has moved between US$1.70 and US$3.44. This gives you a clear view of how...

Axsome Therapeutics (AXSM) Q1 2026 earnings snapshot Axsome Therapeutics (AXSM) has opened 2026 with Q1 revenue of US$191.2 million and a basic EPS loss of US$1.26, alongside a net loss of US$64.5 million, setting a clear benchmark for how the rest of the year might look. The company has seen revenue progress from US$118.8 million in Q4 2024 to US$191.2 million in Q1 2026, while trailing twelve month EPS has moved from a loss of US$5.99 to a loss of US$3.74 as revenue reached US$708.2 million...

Ameresco Q1 2026 earnings in focus Ameresco (AMRC) has come into Q1 2026 with recent quarterly figures that show Q4 2025 revenue at US$581.0 million and basic EPS of US$0.35, alongside trailing twelve month revenue of about US$1.9 billion and basic EPS of US$0.84. The company has seen quarterly revenue move from US$500.9 million in Q3 2024 to US$581.0 million in Q4 2025, while basic EPS over those reported quarters ranged from US$0.24 to US$0.71. This sets up the latest update against a...

Wondering if BeOne Medicines at around US$297.49 is still offering value after a strong run? This article focuses squarely on what that price might really represent. The stock has returned 23.1% over the past year. The shorter term picture shows a 0.2% slip over 7 days, 4.3% over 30 days and 4.4% year to date. Recent news around BeOne Medicines has kept attention on the stock, with investors weighing how company developments align with its current share price. These headlines help frame...

If you are asking whether Fiserv at around US$57.28 is a bargain or a value trap, you will want to understand what the current valuation signals are really saying. The stock has seen a 7% decline over the last 7 days, a 2% gain over the last 30 days, a 12.7% decline year to date, and a 69% decline over the last year, which can change how the market prices its potential and its risks. Recent commentary around Fiserv has focused on its position within diversified financial services and how it...

Wondering if Match Group at around US$37.65 is offering value or just noise? This article breaks down what the current price might be implying about the stock. The stock has returned 1.7% over the last 7 days, 19.8% over the last 30 days, 18.6% year to date and 28.7% over the last year, while the 5 year return sits at a 73.4% decline. These moves come as investors continue to reassess online dating platforms and subscription based business models. Match Group is often in focus during broader...

Adeia (ADEA) sets the tone with Q1 2026 results Adeia (ADEA) opened Q1 2026 with trailing 12 month revenue of US$443.4 million and basic EPS of US$1.02, following a recent quarter where it booked US$182.6 million in revenue and basic EPS of US$0.68. Over the past year, revenue has moved from US$376.0 million to US$443.4 million on a trailing basis, while trailing basic EPS shifted from US$0.59 to US$1.02, giving investors a clearer view of how topline and per share earnings have tracked ahead...

Black Rifle Coffee (BRCC) has just put fresh numbers on the table for Q1 2026, with recent quarters showing revenue of US$112.7 million in Q4 2025 and a basic EPS loss of US$0.03 alongside a net loss of US$3.2 million. Over the past six reported quarters, revenue has ranged from US$89.9 million to US$112.7 million, while basic EPS has stayed in loss-making territory between about US$0.00 and US$0.07 per share. This puts the focus for investors squarely on how margins are trending from...

Donnelley Financial Solutions (DFIN) opened 2026 earnings season with Q1 numbers that come on the heels of Q4 2025 revenue of $172.5 million, basic EPS of $0.24 and net income of $6.2 million. These results are set against a trailing net margin that has moved from 11.8% a year ago to 4.2% after a $92.8 million one-off loss. Over recent quarters, the company has reported revenue ranging between $156.3 million and $218.1 million, while basic EPS has moved from a loss of $1.49 in Q3 2025 to...

Q1 2026 earnings snapshot for CPI Card Group (PMTS) CPI Card Group (PMTS) has opened Q1 2026 earnings season with investors focused on how its recent revenue base of about US$543.5 million and trailing EPS of roughly US$1.32 over the last reported twelve months frame the story after a period of softer profitability. Over the past year, the company has seen revenue progress from US$480.6 million in 2024 Q4 to US$543.5 million in 2025 Q4, while quarterly EPS has moved between US$0.05 and...

Marathon Petroleum Q1 2026 Earnings Snapshot Marathon Petroleum (MPC) heads into its Q1 2026 update with trailing 12 month revenue of about US$133.2b and basic EPS of US$13.26, supported by net income of roughly US$4.0b. Over recent reported quarters, the company has seen quarterly revenue move between US$31.6b and US$35.2b, while basic EPS has ranged from a loss of US$0.24 in Q1 2025 to US$5.13 in Q4 2025. These figures frame a year where earnings growth of 17.5% and a higher net margin of...

If you have been wondering whether Uber Technologies stock at around US$72.95 is a bargain or a value trap, it helps to start with what the recent price and fundamentals are really saying. The stock price has seen a 1.6% decline over the last 7 days, a 1.5% gain over 30 days, a 12.0% decline year to date, and a 15.0% decline over 1 year. It has also shown a 91.0% return over 3 years and 57.9% over 5 years. Recent coverage of Uber has focused on its position as a major player in ride hailing...

Life Time Group Holdings (LTH) opened Q1 2026 with recent quarterly revenue of US$745.1 million in Q4 2025 and basic EPS of US$0.56, while trailing twelve month EPS sat at US$1.71 as net profit margin reached 12.5% over the last year. Over recent periods the company has seen revenue move from US$663.3 million in Q4 2024 to US$745.1 million in Q4 2025, with trailing twelve month net income rising from US$156.2 million to US$373.7 million, setting the stage for investors to weigh stronger...

Shopify (SHOP) opened 2026 with Q1 results that sit against a year of mixed earnings trends, with trailing 12 month revenue of US$11.6b and EPS of US$0.95, alongside a net profit margin of 10.7% compared with 22.7% a year earlier. Over recent quarters, revenue has moved from US$2.16b in Q3 2024 to US$2.36b in Q1 2025 and then to US$3.67b in Q4 2025, while basic EPS shifted from US$0.64 to a loss of US$0.53 and then to US$0.57. This sets a volatile backdrop for the latest print and leaves...

Aviat Networks (AVNW) has just put out its Q3 2026 scorecard, reporting Q2 fiscal 2026 revenue of US$111.5 million and basic EPS of US$0.44 on net income of US$5.7 million. Over the last few quarters, revenue has ranged from US$88.4 million to US$118.2 million, while quarterly basic EPS has swung from a loss of US$0.94 to a profit of US$0.44. On a trailing twelve month basis, EPS is US$1.15 on net income of US$14.6 million from US$446.8 million in revenue. For investors, this mix of higher...

Parker-Hannifin (NYSE:PH) has announced an 11% increase in its quarterly dividend. This marks the company’s 304th consecutive quarterly dividend payment. The new dividend continues Parker-Hannifin’s long history of returning cash to shareholders. Parker-Hannifin, trading at $872.69, has seen its stock return 43.5% over the past year and 197.0% over the past 5 years. Those numbers, alongside a value score of 1, frame this 11% dividend hike as part of a broader story of shareholder-focused...

Jack Welch Management Institute at Strayer University was ranked #8 among U.S. online MBA programs by CEO Magazine. The program was also ranked #30 among global online MBA programs. This is the 10th consecutive year the institute has been included in the U.S. top 10. For investors watching Strategic Education (NasdaqGS:STRA), this recognition highlights an important asset within the group. JWMI sits inside Strayer University, giving the company a branded MBA offering in a crowded online...

TransDigm Group (TDG) has just posted another set of detailed numbers, with Q1 2026 revenue at US$2.3b and basic EPS of US$6.63, supported by trailing twelve month revenue of US$9.1b and EPS of US$31.08. Over recent quarters the company has seen revenue move from US$2.2b in Q4 2024 to between roughly US$2.0b and US$2.4b through 2025, while quarterly EPS ranged from US$5.79 to US$8.47, setting up a picture of robust scale and consistent profit generation as margins hold close to 20%. See our...

If you are wondering whether CRISPR Therapeutics at around US$52 per share looks like an opportunity or a stock to be cautious on, the key is understanding what that price actually builds in. The stock has delivered a 58.0% return over the last year, even though the year to date return is slightly negative at 2.6%, with shorter term moves of 0.6% over 7 days and 5.8% over 30 days adding extra noise on top. Recent headlines around CRISPR Therapeutics have focused on its gene editing platform...

Valaris (VAL) sets the stage with profit-heavy recent results Valaris (VAL) heads into its Q1 2026 update off a very earnings rich 2025 finish, with Q4 revenue of US$537.4 million and basic EPS of US$10.32, underpinned by trailing twelve month net income of US$982.8 million and EPS of US$13.92. Over the past year the company has seen revenue hold around the US$2.4 billion mark on a trailing basis while quarterly revenue moved from US$620.7 million in Q1 2025 to US$537.4 million in Q4 2025,...